Previous reports on allogeneic GM-CSF-secreting tumor cell vaccines in patients with pancreatic adenocarcinoma showed affluence of mononuclear and eosinophilic cells at the vaccination site on day 3 and increased CD3+ cells infiltration on day 7 (15). Here, CSF2 is linked to pancreatic adenocarcinoma.